COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands, SFr in Millions |
1 Months Ended | |
|---|---|---|
|
Jul. 31, 2025
USD ($)
|
Nov. 30, 2022
CHF (SFr)
|
|
| License Agreements | ||
| Other Commitments [Line Items] | ||
| Payment of upfront fees | SFr | SFr 1.0 | |
| Royalty percentage | 1.00% | |
| Payment obligation, term (in years) | 10 years | |
| JCR Pharmaceuticals | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | ||
| Other Commitments [Line Items] | ||
| Upfront payment received | $ 9,250 | |
| Future milestone payment received | 555,000 | |
| JCR Pharmaceuticals | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Development | ||
| Other Commitments [Line Items] | ||
| Future milestone payment received | 40,000 | |
| JCR Pharmaceuticals | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Sales and Royalties | ||
| Other Commitments [Line Items] | ||
| Future milestone payment received | $ 515,000 | |